Corporate Profile

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.

The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.

The U.S. FDA granted 510(k) clearance for the use of the Diamondback Orbital... More >>

Recent News

More >>
Cardiovascular Systems to Webcast Fiscal 2017 Fourth-Quarter Earnings Conference Call Wednesday, August 2 07/12/17
Live Webcast at 3:45 p.m. CT (4:45 p.m. ET) Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2017 fourth-quarter conference call on Wednesday, August 2, 2017, at 3:45 p.m. CT (4:45 p.m. ET). Scott Ward, Chairman, President and Chief Executive Officer, and Larry Betterley, Chief Financial Officer, will discuss CSI’s results for its fiscal fourth quarter ended June 30, 2017, and its financial outlook. The company will issue a post-market earnings release prior to the call on August 2. To access the live webcast, go to the events section of the company’s investor relations website, http://investors.csi360.com/Investors/Events , on the day of the conference call and click on the webcast link. A webcast replay will be available beginning at 6:45 p.m. CT the same day. To participate in the conference call, dial (877) 201-0168 and enter 52200133. Please dial in at least 10 minutes prior to the call. About Cardiovascular Systems, Inc. ...
More >>
Cardiovascular Systems to Present at the JMP Securities Life Sciences Conference 06/14/17
On Wednesday, June 21, 2017 , Cardiovascular Systems’ (NASDAQ: CSII) Chief Financial Officer, Larry Betterley , will present at the JMP Securities Life Sciences Conference at 11:30 a.m. Eastern Time . You may access the live audio webcast and presentation materials in the events section of the company’s investor relations website, http://investors.csi360.com/Investors/Events. About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. , based in St. Paul, Minn. , is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart in a few minutes of treatment time, and address many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. The U.S. FDA granted the first 510(k) clearance for the use of the Orbital Atherectomy System in...
More >>

Upcoming Events

No items found